Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dawid S. Żyła"'
The assembly platform FimD is required to obtain the most stable quaternary structure of type 1 pili
Autor:
Dawid S. Zyla, Thomas Wiegand, Paul Bachmann, Rafal Zdanowicz, Christoph Giese, Beat H. Meier, Gabriel Waksman, Manuela K. Hospenthal, Rudi Glockshuber
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Type 1 pili are important virulence factors of uropathogenic Escherichia coli that mediate bacterial attachment to epithelial cells in the urinary tract. The pilus rod is comprised of thousands of copies of the main structural subunit FimA a
Externí odkaz:
https://doaj.org/article/884d08eb71b24e7aa30ce532b269e3b7
Publikováno v:
The Journal of Biological Chemistry
Journal of Biological Chemistry, 294 (27)
Journal of Biological Chemistry, 294 (27)
Adhesive type 1 pili from enteroinvasive, Gram-negative bacteria mediate attachment to host cells. Up to 3000 copies of the main pilus subunit, FimA, assemble into the filamentous, helical quaternary structure of the pilus rod via a mechanism termed
Autor:
Kevin Wu, Changhan Lee, James C.A. Bardwell, Dawid S. Żyła, Rudi Glockshuber, Patrick Betschinger
Publikováno v:
The EMBO Journal, 39 (20)
EMBO J
EMBO J
Bile salts are secreted into the gastrointestinal tract to aid in the absorption of lipids. In addition, bile salts show potent antimicrobial activity in part by mediating bacterial protein unfolding and aggregation. Here, using a protein folding sen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4182869915a84e47a164559fec661637
https://hdl.handle.net/20.500.11850/451440
https://hdl.handle.net/20.500.11850/451440
Autor:
Kathryn M. Hastie, Xiaoying Yu, Fernanda Ana-Sosa-Batiz, Dawid S. Zyla, Stephanie S. Harkins, Chitra Hariharan, Hal Wasserman, Michelle A. Zandonatti, Robyn Miller, Erin Maule, Kenneth Kim, Kristen M. Valentine, Sujan Shresta, Erica Ollmann Saphire
Publikováno v:
Cell Reports, Vol 42, Iss 5, Pp 112421- (2023)
Summary: Therapeutic antibodies are an important tool in the arsenal against coronavirus infection. However, most antibodies developed early in the pandemic have lost most or all efficacy against newly emergent strains of severe acute respiratory syn
Externí odkaz:
https://doaj.org/article/05a63022e4b143f984c77e5eae90c9db